Hantz Financial Services’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 2241 |
|
|
2025
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 1833 |
|
|
2024
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 1153 |
|
|
2024
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 1131 |
|
|
2024
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 1164 |
|
|
2024
Q1 | $0 | Sell |
8
-1
| -11% | – | ﹤0.01% | 1245 |
|
|
2023
Q4 | $0 | Hold |
9
| – | – | ﹤0.01% | 1173 |
|
|
2023
Q3 | $0 | Hold |
9
| – | – | ﹤0.01% | 1150 |
|
|
2023
Q2 | $0 | Hold |
9
| – | – | ﹤0.01% | 1129 |
|
|
2023
Q1 | $0 | Hold |
9
| – | – | ﹤0.01% | 1155 |
|
|
2022
Q4 | $0 | Sell |
9
-2
| -18% | – | ﹤0.01% | 1119 |
|
|
2022
Q3 | $0 | Buy |
11
+2
| +22% | – | ﹤0.01% | 1104 |
|
|
2022
Q2 | $0 | Hold |
9
| – | – | ﹤0.01% | 1076 |
|
|
2022
Q1 | $0 | Buy |
+9
| New | – | ﹤0.01% | 1079 |
|
|
2021
Q4 | – | Sell |
-7
| Closed | -$1K | – | 886 |
|
|
2021
Q3 | $1K | Sell |
7
-325
| -98% | -$46.4K | ﹤0.01% | 792 |
|
|
2021
Q2 | $37K | Buy |
+332
| New | +$37K | ﹤0.01% | 574 |
|
|
2020
Q4 | – | Sell |
-267
| Closed | -$37K | – | 632 |
|
|
2020
Q3 | $37K | Buy |
+267
| New | +$37K | ﹤0.01% | 473 |
|